Wu; Zhanggui

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wu; Zhanggui.The latest application filed is for "heterocycle compounds and uses thereof".

Company Profile

0.14.12

Wu; Zhanggui - Boston MA
Wu; Zhanggui - Xinchang County CN
Wu; Zhanggui - Brookline MA
Wu; Zhanggui - Hangzhou N/A CN
Wu; Zhanggui - Zhejiang Province CN
Wu; Zhanggui - Hangzhou City CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heterocycle compounds and uses thereof Grant 10,844,074 - Zhai , et al. November 24, 2	2020-11-24
Heterocycle Compounds And Uses Thereof App 20180346479 - ZHAI; Haixiao ; et al.	2018-12-06
2, 6-Di-nitrogen-containing substituted purine derivative, and preparation method, pharmaceutical composition and use thereof Grant 9,718,823 - Wu , et al. August 1, 2	2017-08-01
Compounds and therapeutic use thereof for protein kinase inhibition Grant 9,487,539 - Wu November 8, 2	2016-11-08
2, 6-Di-Nitrogen-Containing Substituted Purine Derivative, And Preparation Method, Pharmaceutical Composition And Use Thereof App 20160207924 - Wu; Guofeng ; et al.	2016-07-21
Compounds and therapeutic use thereof for protein kinase inhibition Grant 9,249,154 - Wu February 2, 2	2016-02-02
Novel Compounds And Therapeutic Use Thereof For Protein Kinase Inhibition App 20150072987 - WU; Zhanggui	2015-03-12
Thienopyridazine compounds, their preparations, pharmaceutical compositions and uses Grant 8,962,626 - Wu February 24, 2	2015-02-24
Compounds and therapeutic use thereof for protein kinase inhibition Grant 8,815,863 - Wu August 26, 2	2014-08-26
2, 6-dinitrogen-containing substituted purine derivatives, the preparation and uses thereof Grant 8,580,763 - Wu , et al. November 12, 2	2013-11-12
Novel Compounds And Therapeutic Use Thereof For Protein Kinase Inhibition App 20130143887 - WU; Zhanggui	2013-06-06
Compounds for protein kinase inhibition Grant 8,318,740 - Wu November 27, 2	2012-11-27
Novel Compounds And Therapeutic Use Thereof For Protein Kinase Inhibition App 20120232082 - Wu; Zhanggui	2012-09-13
Thienopyridazine Compounds, Their Preparations, Pharmaceutical Compositions And Uses App 20110009415 - Wu; Zhanggui	2011-01-13
2, 6-Dinitrogen-Containing Substituted Purine Derivatives, The Preparation And Uses Thereof App 20100144663 - Wu; Zhanggui ; et al.	2010-06-10
Caffeoylquinic Acid Derivatives Containing Nitrogen, And Preparation Method, Pharmaceutical Composition And Usage Thereof App 20100144828 - Wu; Zhanggui ; et al.	2010-06-10
Novel Compounds and Therapeutic Use Thereof for Protein Kinase Inhibition App 20090275585 - Wu; Zhanggui	2009-11-05
N.sup.2-quinoline or isoquinoline substituted purine derivatives Grant 7,399,754 - Wu July 15, 2	2008-07-15
N -quinoline or isoquinoline substituted purine derivatives App 20060293274 - Wu; Zhanggui	2006-12-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.